EMA — authorised 18 February 2016
- Marketing authorisation holder: AstraZeneca AB
- Status: approved
🇪🇺 Zurampic in European Union
EMA authorised Zurampic on 18 February 2016
Marketing authorisation
Zurampic in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in European Union
Frequently asked questions
Is Zurampic approved in European Union?
Yes. EMA authorised it on 18 February 2016.
Who is the marketing authorisation holder for Zurampic in European Union?
AstraZeneca AB holds the EU marketing authorisation.